Hangzhou AGS MedTech Co. Ltd. A Capital Reinvestment Ratio
Hangzhou AGS MedTech Co. Ltd. A capital reinvestment ratio. Hangzhou AGS MedTech Co. Ltd. A (688581) has a Capital Reinvestment Ratio of 0.42x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥151.20 Million) in capital expenditures (CN¥63.47 Million). Check cash flow reinvestment rate of Hangzhou AGS MedTech Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Capital reinvestment ratio of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025. This chart tracks Hangzhou AGS MedTech Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Also explore 688581 net asset momentum to track the company's year-over-year net asset growth rate.
Hangzhou AGS MedTech Co. Ltd. A Capital Reinvestment Ratio by Year (2021–2025)
Hangzhou AGS MedTech Co. Ltd. A capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see 688581 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | CN¥151.20 Million | CN¥63.47 Million | ▲ +167.2% |
| 2024 | 0.16x | CN¥315.80 Million | CN¥49.60 Million | ▼ -32.6% |
| 2023 | 0.23x | CN¥221.45 Million | CN¥51.57 Million | ▼ -39.4% |
| 2022 | 0.38x | CN¥156.38 Million | CN¥60.12 Million | ▲ +190.3% |
| 2021 | 0.13x | CN¥118.25 Million | CN¥15.66 Million | — |